BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35589666)

  • 1. [Intractable Orthostatic Hypotension in Patients with Parkinson's Disease: General Matters about Orthostatic Hypotension and Cautionary Notes through Our Observed Refractory Cases].
    Ishihara T
    Brain Nerve; 2022 May; 74(5):700-707. PubMed ID: 35589666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Orthostatic hypotension and supine hypertension in primary autonomic failure. Pathophysiology, diagnosis and treatment].
    Tykocki T; Guzek K; Nauman P
    Kardiol Pol; 2010 Sep; 68(9):1057-63. PubMed ID: 20859904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central autonomic failures].
    Senard JM; Despas F; Pathak A
    Presse Med; 2012 Nov; 41(11):1122-7. PubMed ID: 22898130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension.
    Hussain IF; Brady CM; Swinn MJ; Mathias CJ; Fowler CJ
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):371-4. PubMed ID: 11511713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
    Senard JM; Brefel-Courbon C; Rascol O; Montastruc JL
    Drugs Aging; 2001; 18(7):495-505. PubMed ID: 11482743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: similarities and differences.
    Iodice V; Low DA; Vichayanrat E; Mathias CJ
    J Neurol Sci; 2011 Nov; 310(1-2):133-8. PubMed ID: 21849175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotensive unawareness in Parkinson's disease-related autonomic dysfunction.
    Slavescu A; Byrne L; Lavan A; Briggs R
    J Hypertens; 2023 Feb; 41(2):362-364. PubMed ID: 36398745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autonomic Nervous System Dysfunction in Patients With Parkinson Disease Having Depression.
    Park HE; Kim JS; Oh YS; Park IS; Park JW; Song IU; Lee KS
    J Geriatr Psychiatry Neurol; 2016 Jan; 29(1):11-7. PubMed ID: 26232405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of orthostatic hypotension.
    Park JW; Okamoto LE; Shibao CA; Biaggioni I
    Auton Neurosci; 2020 Dec; 229():102721. PubMed ID: 32979782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent updates in autonomic research: orthostatic hypotension and cognitive function in Parkinson disease and multiple system atrophy, the skin as a window into synuclein pathology, and RFC1 repeat expansions in hereditary sensory autonomic neuropathies.
    Chompoopong P; Reiter-Campeau S
    Clin Auton Res; 2023 Aug; 33(4):387-389. PubMed ID: 37493897
    [No Abstract]   [Full Text] [Related]  

  • 11. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
    Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD
    Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia.
    Stubendorff K; Aarsland D; Minthon L; Londos E
    PLoS One; 2012; 7(10):e45451. PubMed ID: 23049679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Orthostatic Hypotension in Parkinson's Disease.
    Fanciulli A; Leys F; Falup-Pecurariu C; Thijs R; Wenning GK
    J Parkinsons Dis; 2020; 10(s1):S57-S64. PubMed ID: 32716319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supine hypertension in Parkinson's disease and multiple system atrophy.
    Fanciulli A; Göbel G; Ndayisaba JP; Granata R; Duerr S; Strano S; Colosimo C; Poewe W; Pontieri FE; Wenning GK
    Clin Auton Res; 2016 Apr; 26(2):97-105. PubMed ID: 26801189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality-of-life and burden for caregivers of individuals with neurogenic orthostatic hypotension.
    Gallop K; Pham N; Maclaine G; Saunders E; Black B; Hubig L; Acaster S
    Neurodegener Dis Manag; 2023 Feb; 13(1):35-45. PubMed ID: 36382590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic Dysfunction in Parkinson's Disease.
    Pfeiffer RF
    Neurotherapeutics; 2020 Oct; 17(4):1464-1479. PubMed ID: 32789741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.
    Pathak A; Senard JM
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):393-403. PubMed ID: 15151485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson's disease and multiple system atrophy.
    Vichayanrat E; Low DA; Iodice V; Stuebner E; Hagen EM; Mathias CJ
    Eur J Neurol; 2017 Jan; 24(1):90-97. PubMed ID: 27718292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.
    Clement G; Cavillon G; Vuillier F; Bouhaddi M; Béreau M
    Rev Neurol (Paris); 2024; 180(1-2):79-93. PubMed ID: 38216420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience.
    Mathias CJ
    Clin Auton Res; 2008 Mar; 18 Suppl 1():25-9. PubMed ID: 18368304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.